Douglas G. Millar on Muck Rack

Douglas G. Millar

As seen in: Nature, The Aquila Report
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Douglas G.

Contact Douglas G., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial

|
By Ana C. Veneziani, Stephanie Lheureux, Douglas G. Millar, Neesha Dhani, Ilaria Colombo, Ainhoa Madariaga, Pamela Piña, Joshua Lee, Lisa Wang, Xuan Li, Ben Wang, Amit M Oza, Swati Atale, Yin-Ling Chan, Janelle Ramsahai, Judy Quintos, Valerie Bowering, Pam Ohashi
| Nature Verified
Abstract This investigator-initiated, open-label phase 1/2 clinical trial evaluates maveropepimut-S, a survivin-targeting vaccine, combined with pembrolizumab and low-dose cyclophosphamide in patients with recurrent epithelial ovarian cancer (ClinicalTrials.gov identifier: NCT03029403). The primary endpoints are safety and clinical efficacy measured by overall response rate and disease control rate.
Open in Who Shared Issue with article?

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma

|
By Munehide Nakatsugawa, Muhammed Rahman, Linh Nguyen, linh nguyễn, Douglas G. Millar, David Mulder, Yukiko Matsunaga, Yuki Kagoya, Tingxi Guo, Mark Anczurowski, Brian Burt, Alexandra M. Easson, Danny Ghazarian, Trevor J. Pugh, Marcus Butler, Tak W. Mak, Pamela S Ohashi, Naoto Hirano, Kenji Murata, Kenji Sugata, Hiroshi Saijo, Chung-Hsi Wang, Dalam Ly, Kayoko Saso, Michael Reedijk, David Goldstein
| eLife
Abstract HLA-restricted T cell responses can induce antitumor effects in cancer patients. Previous human T cell research has largely focused on the few HLA alleles prevalent in a subset of ethnic groups.
Open in Who Shared Issue with article?

Should I Join A Church?

|
By Douglas G. Millar
| The Aquila Report Verified
Written by Douglas G. Millar | Sunday, December 30, 2018 Belonging to a particular church is vital to the Christian. In the New Testament there is no such person as a Christian who is not a church member. Conversion was described as ‘the Lord adding to the church’ (Acts 2:47). There was no spiritual drifting.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified